4YX.F RED LIGHT HOLLAND CORP.
- Market cap
- EUR 7.74M
- P/E
- -
- P/B
- 0.34x
- ROE
- -39.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is 4YX.F undervalued?
Graham numberThe Graham number of RED LIGHT HOLLAND CORP. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
RED LIGHT HOLLAND CORP. fundamental analysis
No fundamental analysis for RED LIGHT HOLLAND CORP. yet.
RED LIGHT HOLLAND CORP. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About RED LIGHT HOLLAND CORP.
Rhelion Life Sciences Corp. engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe. The company is also involved in the selection, distribution, and export of truffles, cannabidiol products, cannabis seeds, headshop products, growshop goods, cannabis bake house muffins, cookies, and cakes. Its products also include PEX010, a natural psilocybin drug candidate for depression, PTSD, …
Full company profileRED LIGHT HOLLAND CORP. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
RED LIGHT HOLLAND CORP. annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 2.33M | 3.95M | 4.75M | 4.94M | 4.20M | 744K |
| Gross Profit | 618K | 1.71M | 2.02M | 1.91M | 1.59M | 679K |
| Operating Income | -9.51M | -4.95M | -6.19M | -4.21M | -4.12M | -5.61M |
| EBITDA | - | -5.27M | -6.58M | -3.35M | -6.75M | -5.55M |
| Net Income | -14.4M | -5.40M | -7.63M | -4.04M | -6.10M | -7.47M |
| EPS | -0.04 | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 |
| Balance Sheet | ||||||
| Total Assets | 32.9M | 30.1M | 24.1M | 21.2M | 14.6M | 21.9M |
| Total Liabilities | 3.78M | 3.80M | 3.82M | 3.87M | 3.35M | 3.82M |
| Shareholders' Equity | 28.5M | 26.1M | 20.1M | 17.4M | 12.0M | 18.8M |
| Cash & Short-term Investments | 26.1M | 18.5M | 14.2M | 12.3M | 8.47M | 2.60M |
| Cash Flow | ||||||
| Operating Cash Flow | -4.88M | -4.39M | -3.23M | -1.48M | -2.42M | -3.56M |
| Capital Expenditure | 407K | 2.06M | 694K | 531K | 1.23M | 0.00 |
| Free Cash Flow | -5.28M | -6.45M | -3.92M | -2.01M | -3.65M | -3.56M |
| Ratios | ||||||
| ROE | -50.5% | -20.7% | -38.0% | -23.3% | -51.0% | -39.7% |
| ROA | -43.6% | -17.9% | -31.7% | -19.0% | -41.9% | -34.2% |
| Net Profit Margin | -617.8% | -136.7% | -160.5% | -81.8% | -145.4% | -1,003.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
RED LIGHT HOLLAND CORP. dividends
RED LIGHT HOLLAND CORP. has not paid dividends in the last 6 fiscal years.
Who owns RED LIGHT HOLLAND CORP.
- Insiders 5.90%
- Institutions 0.00%
- Public & others 94.10%
- Shares outstanding 596M
- Free float 575M
RED LIGHT HOLLAND CORP. company profile
- Company name
- RED LIGHT HOLLAND CORP.
- Ticker
- 4YX.F
- ISIN
- CA75671E1097
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- March
- Address
- 1 Adelaide Street East, Toronto, ON, Canada, M5C 2V9
- Phone
- 647 204 7129
- Website
- rhelion.com
About RED LIGHT HOLLAND CORP.
Rhelion Life Sciences Corp. engages in the production, growth, and sale of functional mushrooms and mushroom home grow kits to the recreational market in North America and Europe. The company is also involved in the selection, distribution, and export of truffles, cannabidiol products, cannabis seeds, headshop products, growshop goods, cannabis bake house muffins, cookies, and cakes. Its products also include PEX010, a natural psilocybin drug candidate for depression, PTSD, cancer-related distress and substance use disorders; IBEXX, a botanical ibogaine drug candidate for substance use disorders; and MB2500, a whole-leaf coca extract drug candidate for neuropsychiatric indications. It sells its products under the iMicrodose, Maka, Happy Caps, and Mistercap's brands through brick-and-mortar SmartShops, as well as through online stores. The company was formerly known as Red Light Holland Corp. and changed its name to Rhelion Life Sciences Corp. in August 2026. Rhelion Life Sciences Corp. is based in Toronto, Canada.
RED LIGHT HOLLAND CORP. management
8- Mr. Todd Michael ShapiroCo-Founder, CEO & Director · born 1975
- Mr. Hans DerixPresident of RLH Netherlands B.V.
- Mr. Benjamin LightburnPresident & Director · born 1986
- Ms. Lisa RankenChief Operating Officer · born 1984
- Mr. Karim RashidHead of Design
- Mr. Russell PetersChief Creative Officer
- Ms. Sarit HashkesChief Technology Innovation Officer
- Mr. Shimshon Posen J.D.Corporate Secretary